Topics

The US FDA Acts To Bolster Adverse Event Reporting For Compounded Drugs

13:23 EDT 12 Sep 2019 | SCRIP

After discovering one firm suppressed over 4,000 compounded-hormone adverse event reports, agency leans on compounders and outsourcers to improve reporting.

      

Related Stories

 

Original Article: The US FDA Acts To Bolster Adverse Event Reporting For Compounded Drugs

NEXT ARTICLE

More From BioPortfolio on "The US FDA Acts To Bolster Adverse Event Reporting For Compounded Drugs"

Quick Search

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...